Navigation Links
Malaria parasite caught red-handed invading blood cells
Date:1/19/2011

Australian scientists using new image and cell technologies have for the first time caught malaria parasites in the act of invading red blood cells. The researchers, from the Walter and Eliza Hall Institute in Melbourne, Australia, and the University of Technology, Sydney (UTS), achieved this long-held aim using a combination of electron, light and super resolution microscopy, a technology platform new to Australia.

The detailed look at what occurs as the parasite burrows through the walls of red blood cells provides new insights into the molecular and cellular events that drive cell invasion and may pave the way for developing new treatments for malaria. Institute researchers Dr Jake Baum, Mr David Riglar, Dr Dave Richard and colleagues from the institute's Infection and Immunity division led the research with colleagues from the i3 institute at UTS.

Dr Baum said the real breakthrough for the research team had been the ability to capture high-resolution images of the parasite at each and every stage of invasion, and to do so reliably and repeatedly. Their findings are published in today's issue of the journal Cell Host & Microbe.

"It is the first time we've been able to actually visualise this process in all its molecular glory, combining new advances developed at the institute for isolating viable parasites with innovative imaging technologies," Dr Baum said.

"Super resolution microscopy has opened up a new realm of understanding into how malaria parasites actually invade the human red blood cell. Whilst we have observed this miniature parasite drive its way into the cell before, the beauty of the new imaging technology is that it provides a quantum leap in the amount of detail we can see, revealing key molecular and cellular events required for each stage of the invasion process."

The imaging technology, called OMX 3D SIM super resolution microscopy, is a powerful new 3D tool that captures cellular process
'/>"/>

Contact: Penny Fannin
fannin@wehi.edu.au
61-417-125-700
Walter and Eliza Hall Institute
Source:Eurekalert  

Page: 1 2 3

Related biology technology :

1. Advanced Life Sciences Announces US Army Collaboration to Research and Develop Restanza for the Treatment of Malaria
2. The first malaria-proof mosquito
3. Advanced Life Sciences Announces Restanza(TM) Shows Efficacy Against Malaria
4. Sanaria Inc. Receives Multi-Year U.S. NIH Phase II Small Business Innovation Research Grant to Develop a Genetically Attenuated Whole Parasite Malaria Vaccine
5. Scientists transplant nose of mosquito, advance fight against malaria
6. Discovery provides new drug targets for malaria cure
7. First genetically engineered malaria vaccine to enter human trials
8. GenVec Expands Contract Supporting Malaria Vaccine Program
9. Fincor (FINC) Makes a Share Transfer and Enters the Market With ACTRx a New Malaria and Dengue Fever Treatment
10. Chimerix Joins International Network of Organizations to Cure Malaria
11. ImmunoVaccine Technologies Signs Agreement with National Institutes of Health to Explore Vaccines for HIV and Malaria
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Malaria parasite caught red-handed invading blood cells
(Date:12/24/2014)... NEW YORK , Dec. 23, 2014 ... pilot study of mazindol in children with attention deficit/hyperactivity ... in December 2014 . The paper, ... with attention deficit/hyperactivity disorder" ( Konofal et al, ... 1;8:2321-2332. eCollection 2014 ) shows that mazindol might ...
(Date:12/22/2014)... 2014  Alternative Energy & Environmental Solutions, Inc., ... a letter of intent to acquire BioTechPharma Corporation, ... a nanotechnology-based development platform used to create drug ... on-site collection and testing to identify infectious disease, ... an immediate, non-invasive and cost-effective manner. ...
(Date:12/22/2014)... 22, 2014 ITRA Global, one of ... of commercial real estate, has further expanded its global ... Perth and Brisbane, Western Australia, reports Mylinda Vick, CCIM, ... ITRA Global / ACORPP (Australian Corporate Property and ... company providing property services to a wide range of ...
(Date:12/19/2014)... BioPlus Specialty Pharmacy (BioPlus), one of ... Nick Maroulis, Pharm.D. to the newly created position of ... this position, Dr. Maroulis will continue to manage the ... our multi-site pharmacies as the company expands. Dr. Maroulis ... time he has served in many different capacities in ...
Breaking Biology Technology:Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 2Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 3ALNE Announces Intention To Acquire BioTechPharma 2ITRA Global Continues International Expansion in Perth and Brisbane, Australia 2BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2
... , AMES, Iowa , ... technology company, announced that it will embark a $5.3 million ... $44 million DOE Investment for Advanced Biofuels Research and ... Advanced Biofuels and Bioproducts (NAABB).  Catilin and its partner, Iowa ...
... 2008 08/07 2009 ... MEUR %Sales Var.% MEUR %Sales Var.%, Southern Europe (1) 36.4 ... 11.3 23 17 13.1 23 16, ... 1.5 3 (25), SLIT ...
... , , ... AB (publ),and BioChromix AB announced today the formation of BioChromix Pharma ... its unique,knowledge of molecular chemistry. Karolinska Development will initially take,28 percent ... are very excited about BioChromix Pharma as they have a novel,approach ...
Cached Biology Technology:Catilin Contributes Key Extraction, Sequestration and Conversion Technologies to NAABB Consortium Developing Algal Biofuels 2Catilin Contributes Key Extraction, Sequestration and Conversion Technologies to NAABB Consortium Developing Algal Biofuels 3STALLERGENES : Sales Guidance Exceeded : EUR193 Million, up 13% 2STALLERGENES : Sales Guidance Exceeded : EUR193 Million, up 13% 3Karolinska Development Expands its Life Science Portfolio With BioChromix Pharma 2Karolinska Development Expands its Life Science Portfolio With BioChromix Pharma 3
(Date:12/15/2014)... 12, 2014 Research and Markets ... the "Global Facial Recognition Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 Facial recognition is ... Facial recognition system measures the overall facial feature ... mouth, and the distance between eyes. Facial recognition ...
(Date:12/11/2014)... ST. PAUL, Minn. , Dec. 10, 2014 ... in wireless physiologic monitoring, has released a new ... changing needs of preclinical toxicology researchers. M series, ... to help toxicologists collect the best possible physiologic ... studies. Adding functional endpoints to toxicology ...
(Date:12/10/2014)... , Dec. 9, 2014 CIE San Diego ... that provides the connective tissue that enhances care coordination ... to easily share client-level information; earned a second $1 ... to organizations serving seniors aging in community and; will ... on December 11 th 4-6p. CIE ...
Breaking Biology News(10 mins):Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3New telemetry implants expected to change how large animal toxicology studies are conducted 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4
... changing climate there,s a good chance that forest fires in ... and according to one expert speaking today at a professional ... this region is difficult to predict, will always be variable, ... understand, however, that fire is not only inevitable but also ...
... NEW YORK (February 24, 2010) An international ... used mouse embryonic stem cells to replace diseased retinal ... retinitis pigmentosa. This strategy could potentially become a new ... that affects approximately one in 3,000 to 4,000 people, ...
... ensure that people with rare forms of cancer are not denied ... major European cancer conference to be held in Milan on 9 ... same right to receive proper treatment as all other patients", said ... at the Milan Istituto Nazionale Tumori and co-chair of the ESMO ...
Cached Biology News:More frequent fires could aid ecosystems 2More frequent fires could aid ecosystems 3Stem cells restore sight in mouse model of retinitis pigmentosa 2Stem cells restore sight in mouse model of retinitis pigmentosa 3'Rare' cancers in the spotlight at major European conference 2
X-prolyl aminopeptidase (aminopeptidase P) 1, soluble...
2,4,6, Trinitrophenyl hapten is conjugated to lipopolysaccharide (LPS)....
SHEEP ANTI BOVINE LACTOPEROXIDASE...
... the ultimate in utility and flexibility press-to-seal ... the needs of the researcher. They are ... or as sheet material that can be ... isolators are autoclavable and non-cytotoxic and can ...
Biology Products: